The kinetic stability of MHC class II:peptide complexes is a key parameter that dictates immunodominance.

T cell priming to exogenous antigens reflects regulated antigen processing in dendritic cells, subsequent homing to lymph nodes, sustained interactions between T cells and antigen-bearing dendritic cells, and, ultimately, selective T cell activation and differentiation. In this study, we test the hypothesis that an intrinsic property of the class II:peptide complex is a key determinant that dictates the specificity of an emerging CD4 T cell response. We found that immunodominant peptides possess extremely long half-lives with class II molecules (t(1/2) > 150 hr), whereas cryptic peptides displayed half-lives of less than 10 hr. Furthermore, and most importantly, by using a peptide shuttle vector and four independent antigens, we demonstrate a direct, causative relationship between the half-life of peptide epitopes and their immunogenicity in vivo. Taken collectively, our results suggest the half-life of class II:peptide complexes is the primary parameter that dictates the ultimate hierarchy of the elicited T cell response.

[1]  B. Evavold,et al.  Modification of peptide interaction with MHC creates TCR partial agonists. , 2004, Cellular immunology.

[2]  R. Locksley,et al.  Expression cloning of a protective Leishmania antigen. , 1995, Science.

[3]  L. Stern,et al.  A three-step kinetic mechanism for peptide binding to MHC class II proteins. , 2000, Biochemistry.

[4]  T. Hunkapiller,et al.  Differential tolerance is induced in T cells recognizing distinct epitopes of myelin basic protein. , 1998, Immunity.

[5]  N. Viner,et al.  Destructive processing by asparagine endopeptidase limits presentation of a dominant T cell epitope in MBP , 2002, Nature Immunology.

[6]  H. Mcconnell,et al.  Kinetic intermediates in the reactions between peptides and proteins of major histocompatibility complex class II. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[7]  B. Chain,et al.  Protein degradation in MHC class II antigen presentation: opportunities for immunomodulation. , 2000, Seminars in Cell and Developmental Biology.

[8]  E. Sercarz,et al.  Cutting Edge: Introduction of an Endopeptidase Cleavage Motif into a Determinant Flanking Region of Hen Egg Lysozyme Results in Enhanced T Cell Determinant Display1 , 2000, The Journal of Immunology.

[9]  D. Weber,et al.  HLA-DM and the MHC class II antigen presentation pathway , 1999, Immunologic research.

[10]  Philippa Marrack,et al.  Epitope dominance, competition and T cell affinity maturation. , 2003, Current opinion in immunology.

[11]  M. Vrljic,et al.  Formation of a highly peptide-receptive state of class II MHC. , 1998, Immunity.

[12]  G. Hämmerling,et al.  Quality control of MHC class II associated peptides by HLA-DM/H2-M. , 1999, Seminars in immunology.

[13]  A. Sant,et al.  The inability of the nonobese diabetic class II molecule to form stable peptide complexes does not reflect a failure to interact productively with DM. , 1998, Journal of immunology.

[14]  S. Stevanović,et al.  Cathepsin G, and Not the Asparagine-Specific Endoprotease, Controls the Processing of Myelin Basic Protein in Lysosomes from Human B Lymphocytes1 , 2004, The Journal of Immunology.

[15]  Paul V. Lehmann,et al.  Endogenous Myelin Basic Protein Inactivates the High Avidity T Cell Repertoire , 1998, The Journal of experimental medicine.

[16]  H. Grey,et al.  Structural analysis of peptides capable of binding to more than one Ia antigen. , 1989, Journal of immunology.

[17]  B. Evavold,et al.  DO11.10 and OT-II T Cells Recognize a C-Terminal Ovalbumin 323–339 Epitope1 , 2000, The Journal of Immunology.

[18]  R. Doebele,et al.  Accessory molecules for MHC class II peptide loading. , 2000, Current opinion in immunology.

[19]  Francisco A. Chaves,et al.  Replacement of the membrane proximal region of I-A(d) MHC class II molecule with I-E-derived sequences promotes production of an active and stable soluble heterodimer without altering peptide-binding specificity. , 2005, Journal of immunological methods.

[20]  Mark M Davis,et al.  Continuous T cell receptor signaling required for synapse maintenance and full effector potential , 2003, Nature Immunology.

[21]  A. Sant,et al.  Invariant chain and DM edit self-peptide presentation by major histocompatibility complex (MHC) class II molecules , 1996, The Journal of experimental medicine.

[22]  Ira Mellman,et al.  Dendritic Cells Specialized and Regulated Antigen Processing Machines , 2001, Cell.

[23]  H. Grey,et al.  I-Ad-binding peptides derived from unrelated protein antigens share a common structural motif. , 1988, Journal of immunology.

[24]  H. Mcconnell,et al.  REACTIONS OF PEPTIDES WITH CLASS II PROTEINS OF THE MAJOR HISTOCOMPATIBILITY COMPLEX , 1995 .

[25]  A Sette,et al.  The Interaction between Protein‐Derived Immunogenic Peptides and Ia , 1987, Immunological reviews.

[26]  R. Titus,et al.  Higher frequency of Leishmania major-specific L3T4+ T cells in susceptible BALB/c as compared with resistant CBA mice. , 1986, Journal of immunology.

[27]  A. Hill The Combinations of Haemoglobin with Oxygen and with Carbon Monoxide. I. , 1913, The Biochemical journal.

[28]  A. Khoruts,et al.  In vivo activation of antigen-specific CD4 T cells. , 2001, Annual review of immunology.

[29]  T. Mosmann,et al.  In Vivo Priming of Cd4 T Cells That Produce Interleukin (Il)-2 but Not IL-4 or Interferon (Ifn)-γ, and Can Subsequently Differentiate into IL-4–Or IFN-γ–Secreting Cells , 2001, The Journal of experimental medicine.

[30]  M. Coughlan,et al.  Presentation of the Goodpasture Autoantigen to CD4 T Cells Is Influenced More by Processing Constraints Than by HLA Class II Peptide Binding Preferences* , 1998, The Journal of Biological Chemistry.

[31]  A. Sant,et al.  Cutting edge: a single, essential hydrogen bond controls the stability of peptide-MHC class II complexes. , 1999, Journal of immunology.

[32]  Kevin E. Swier,et al.  Control of Leishmania major by a monoclonal alpha beta T cell repertoire. , 1998, Journal of immunology.

[33]  P. A. Peterson,et al.  Crystal structures of two I-Ad-peptide complexes reveal that high affinity can be achieved without large anchor residues. , 1998, Immunity.

[34]  S. Sadegh-Nasseri,et al.  Stable peptide binding to MHC class II molecule is rapid and is determined by a receptive conformation shaped by prior association with low affinity peptides. , 1999, Journal of immunology.

[35]  David L. Woodland,et al.  The Majority of Immunogenic Epitopes Generate CD4+ T Cells That Are Dependent on MHC Class II-Bound Peptide-Flanking Residues1 , 2002, The Journal of Immunology.

[36]  R. Phelps,et al.  The Goodpasture antigen is expressed in the human thymus. , 2001, Kidney international.

[37]  R. Locksley,et al.  TH1 and TH2 cell antigen receptors in experimental leishmaniasis. , 1993, Science.

[38]  A. Cope,et al.  Relationship between kinetic stability and immunogenicity of HLA‐DR4/peptide complexes , 2002, European journal of immunology.

[39]  H. Mcconnell,et al.  A kinetic intermediate in the reaction of an antigenic peptide and I–Ek , 1989, Nature.

[40]  T. Lybrand,et al.  Ovalbumin(323-339) peptide binds to the major histocompatibility complex class II I-A(d) protein using two functionally distinct registers. , 1999, Biochemistry.

[41]  A. Sant,et al.  Dm Determines the Cryptic and Immunodominant Fate of T Cell Epitopes , 2000, The Journal of experimental medicine.

[42]  G. Hämmerling,et al.  How HLA-DM edits the MHC class II peptide repertoire: survival of the fittest? , 1997, Immunology today.

[43]  H. Mcdevitt,et al.  A role for non-MHC genetic polymorphism in susceptibility to spontaneous autoimmunity. , 1994, Immunity.

[44]  A. Taylor,et al.  Identification of eight determinants in the hemagglutinin molecule of influenza virus A/PR/8/34 (H1N1) which are recognized by class II-restricted T cells from BALB/c mice , 1991, Journal of virology.

[45]  M. Hofnung,et al.  Expression of heterologous peptides at two permissive sites of the MalE protein: antigenicity and immunogenicity of foreign B-cell and T-cell epitopes. , 1992, Gene.

[46]  J. Blum,et al.  Antigen-presenting cells and the selection of immunodominant epitopes. , 1997, Critical reviews in immunology.

[47]  K. Wucherpfennig,et al.  Structural Factors Contributing to DM Susceptibility of MHC Class II/Peptide Complexes1 , 2002, The Journal of Immunology.

[48]  Ronald N Germain,et al.  In vivo antigen presentation. , 2004, Current opinion in immunology.

[49]  D. Kioussis,et al.  Low avidity recognition of self-antigen by T cells permits escape from central tolerance. , 1995, Immunity.

[50]  Francisco A. Chaves,et al.  The relationship between immunodominance, DM editing, and the kinetic stability of MHC class II:peptide complexes , 2005, Immunological reviews.

[51]  R. Locksley,et al.  Rapid expansion and IL-4 expression by Leishmania-specific naive helper T cells in vivo. , 2002, Immunity.

[52]  F. Sallusto,et al.  Antigen decoding by T lymphocytes: from synapses to fate determination , 2001, Nature Immunology.

[53]  A. Miller,et al.  Dominance and crypticity of T cell antigenic determinants. , 1993, Annual review of immunology.

[54]  E. Sercarz,et al.  Immunodominance is independent of structural constraints: each region within hen eggwhite lysozyme is potentially available upon processing of native antigen. , 1997, Journal of immunology.

[55]  S. Sadegh-Nasseri,et al.  The Magnitude of TCR Engagement Is a Critical Predictor of T Cell Anergy or Activation1 , 2004, The Journal of Immunology.